Logo image of BXC

BLUELINX HOLDINGS INC (BXC) Stock Fundamental Analysis

USA - NYSE:BXC - US09624H2085 - Common Stock

61.615 USD
-0.18 (-0.3%)
Last: 11/7/2025, 10:52:51 AM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to BXC. BXC was compared to 51 industry peers in the Trading Companies & Distributors industry. While BXC has a great health rating, its profitability is only average at the moment. BXC does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year BXC was profitable.
In the past year BXC had a positive cash flow from operations.
BXC had positive earnings in each of the past 5 years.
Each year in the past 5 years BXC had a positive operating cash flow.
BXC Yearly Net Income VS EBIT VS OCF VS FCFBXC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

1.2 Ratios

The Return On Assets of BXC (1.79%) is worse than 60.78% of its industry peers.
BXC has a Return On Equity (4.57%) which is in line with its industry peers.
Looking at the Return On Invested Capital, with a value of 3.08%, BXC is doing worse than 68.63% of the companies in the same industry.
BXC had an Average Return On Invested Capital over the past 3 years of 11.49%. This is in line with the industry average of 10.20%.
The 3 year average ROIC (11.49%) for BXC is well above the current ROIC(3.08%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 1.79%
ROE 4.57%
ROIC 3.08%
ROA(3y)8.8%
ROA(5y)11.32%
ROE(3y)22.02%
ROE(5y)56.9%
ROIC(3y)11.49%
ROIC(5y)14.44%
BXC Yearly ROA, ROE, ROICBXC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200 300

1.3 Margins

Looking at the Profit Margin, with a value of 0.96%, BXC is doing worse than 60.78% of the companies in the same industry.
In the last couple of years the Profit Margin of BXC has declined.
BXC's Operating Margin of 2.09% is on the low side compared to the rest of the industry. BXC is outperformed by 70.59% of its industry peers.
BXC's Operating Margin has improved in the last couple of years.
The Gross Margin of BXC (15.94%) is worse than 86.27% of its industry peers.
In the last couple of years the Gross Margin of BXC has grown nicely.
Industry RankSector Rank
OM 2.09%
PM (TTM) 0.96%
GM 15.94%
OM growth 3Y-33.48%
OM growth 5Y28.68%
PM growth 3Y-36.19%
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y4.13%
BXC Yearly Profit, Operating, Gross MarginsBXC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so BXC is still creating some value.
Compared to 1 year ago, BXC has less shares outstanding
Compared to 5 years ago, BXC has less shares outstanding
Compared to 1 year ago, BXC has an improved debt to assets ratio.
BXC Yearly Shares OutstandingBXC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
BXC Yearly Total Debt VS Total AssetsBXC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 3.41 indicates that BXC is not in any danger for bankruptcy at the moment.
BXC has a better Altman-Z score (3.41) than 68.63% of its industry peers.
BXC has a Debt/Equity ratio of 0.96. This is a neutral value indicating BXC is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.96, BXC perfoms like the industry average, outperforming 41.18% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.96
Debt/FCF N/A
Altman-Z 3.41
ROIC/WACC0.34
WACC9.05%
BXC Yearly LT Debt VS Equity VS FCFBXC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

BXC has a Current Ratio of 4.55. This indicates that BXC is financially healthy and has no problem in meeting its short term obligations.
BXC has a better Current ratio (4.55) than 94.12% of its industry peers.
BXC has a Quick Ratio of 2.94. This indicates that BXC is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 2.94, BXC belongs to the best of the industry, outperforming 92.16% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.55
Quick Ratio 2.94
BXC Yearly Current Assets VS Current LiabilitesBXC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

3

3. Growth

3.1 Past

The earnings per share for BXC have decreased strongly by -76.69% in the last year.
The earnings per share for BXC have been decreasing by -40.26% on average. This is quite bad
BXC shows a decrease in Revenue. In the last year, the revenue decreased by -5.86%.
The Revenue has been growing slightly by 2.28% on average over the past years.
EPS 1Y (TTM)-76.69%
EPS 3Y-40.26%
EPS 5YN/A
EPS Q2Q%-76.92%
Revenue 1Y (TTM)-5.86%
Revenue growth 3Y-11.62%
Revenue growth 5Y2.28%
Sales Q2Q%0.21%

3.2 Future

The Earnings Per Share is expected to decrease by -26.58% on average over the next years. This is quite bad
The Revenue is expected to grow by 2.57% on average over the next years.
EPS Next Y-77.32%
EPS Next 2Y-26.58%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year0.87%
Revenue Next 2Y2.57%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
BXC Yearly Revenue VS EstimatesBXC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1B 2B 3B 4B
BXC Yearly EPS VS EstimatesBXC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2019 2020 2021 2022 2023 2024 2025 2026 0 10 20 30

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 30.35 indicates a quite expensive valuation of BXC.
BXC's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 25.67, BXC is valued at the same level.
With a Price/Forward Earnings ratio of 17.92, BXC is valued on the expensive side.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BXC is on the same level as its industry peers.
BXC's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 31.86.
Industry RankSector Rank
PE 30.35
Fwd PE 17.92
BXC Price Earnings VS Forward Price EarningsBXC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

82.35% of the companies in the same industry are more expensive than BXC, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.19
BXC Per share dataBXC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 100 200 300

4.3 Compensation for Growth

BXC's earnings are expected to decrease with -26.58% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-26.58%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

BXC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BLUELINX HOLDINGS INC

NYSE:BXC (11/7/2025, 10:52:51 AM)

61.615

-0.18 (-0.3%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)11-04 2025-11-04/amc
Earnings (Next)02-16 2026-02-16/amc
Inst Owners96.47%
Inst Owner Change-1.8%
Ins Owners2.21%
Ins Owner Change0.56%
Market Cap486.14M
Revenue(TTM)2.95B
Net Income(TTM)28.40M
Analysts77.5
Price Target83.64 (35.75%)
Short Float %6.44%
Short Ratio5.61
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-11.89%
Min EPS beat(2)-24.67%
Max EPS beat(2)0.88%
EPS beat(4)3
Avg EPS beat(4)13.48%
Min EPS beat(4)-24.67%
Max EPS beat(4)61.56%
EPS beat(8)6
Avg EPS beat(8)23.04%
EPS beat(12)8
Avg EPS beat(12)14.37%
EPS beat(16)12
Avg EPS beat(16)22.17%
Revenue beat(2)0
Avg Revenue beat(2)-1.43%
Min Revenue beat(2)-1.64%
Max Revenue beat(2)-1.23%
Revenue beat(4)1
Avg Revenue beat(4)-1.24%
Min Revenue beat(4)-2.52%
Max Revenue beat(4)0.42%
Revenue beat(8)2
Avg Revenue beat(8)-2.07%
Revenue beat(12)2
Avg Revenue beat(12)-3.74%
Revenue beat(16)6
Avg Revenue beat(16)-0.03%
PT rev (1m)0%
PT rev (3m)-10.14%
EPS NQ rev (1m)-9.37%
EPS NQ rev (3m)-47.03%
EPS NY rev (1m)-3.21%
EPS NY rev (3m)-53.45%
Revenue NQ rev (1m)-0.86%
Revenue NQ rev (3m)-1.88%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.19%
Valuation
Industry RankSector Rank
PE 30.35
Fwd PE 17.92
P/S 0.16
P/FCF N/A
P/OCF 24.5
P/B 0.78
P/tB 0.9
EV/EBITDA 7.19
EPS(TTM)2.03
EY3.29%
EPS(NY)3.44
Fwd EY5.58%
FCF(TTM)-3.02
FCFYN/A
OCF(TTM)2.51
OCFY4.08%
SpS373.54
BVpS78.75
TBVpS68.56
PEG (NY)N/A
PEG (5Y)N/A
Graham Number59.97
Profitability
Industry RankSector Rank
ROA 1.79%
ROE 4.57%
ROCE 4.59%
ROIC 3.08%
ROICexc 4.33%
ROICexgc 4.73%
OM 2.09%
PM (TTM) 0.96%
GM 15.94%
FCFM N/A
ROA(3y)8.8%
ROA(5y)11.32%
ROE(3y)22.02%
ROE(5y)56.9%
ROIC(3y)11.49%
ROIC(5y)14.44%
ROICexc(3y)16.25%
ROICexc(5y)17.76%
ROICexgc(3y)18%
ROICexgc(5y)19.38%
ROCE(3y)17.1%
ROCE(5y)21.48%
ROICexgc growth 3Y-37.08%
ROICexgc growth 5Y30.14%
ROICexc growth 3Y-37.9%
ROICexc growth 5Y30.02%
OM growth 3Y-33.48%
OM growth 5Y28.68%
PM growth 3Y-36.19%
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y4.13%
F-Score3
Asset Turnover1.86
Health
Industry RankSector Rank
Debt/Equity 0.96
Debt/FCF N/A
Debt/EBITDA 6
Cap/Depr 115.37%
Cap/Sales 1.48%
Interest Coverage 1.33
Cash Conversion 19.97%
Profit Quality N/A
Current Ratio 4.55
Quick Ratio 2.94
Altman-Z 3.41
F-Score3
WACC9.05%
ROIC/WACC0.34
Cap/Depr(3y)106.72%
Cap/Depr(5y)76.81%
Cap/Sales(3y)1.01%
Cap/Sales(5y)0.7%
Profit Quality(3y)260.74%
Profit Quality(5y)177.95%
High Growth Momentum
Growth
EPS 1Y (TTM)-76.69%
EPS 3Y-40.26%
EPS 5YN/A
EPS Q2Q%-76.92%
EPS Next Y-77.32%
EPS Next 2Y-26.58%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.86%
Revenue growth 3Y-11.62%
Revenue growth 5Y2.28%
Sales Q2Q%0.21%
Revenue Next Year0.87%
Revenue Next 2Y2.57%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-48.23%
EBIT growth 3Y-41.21%
EBIT growth 5Y31.62%
EBIT Next Year-5.4%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-105.85%
FCF growth 3Y-29.86%
FCF growth 5YN/A
OCF growth 1Y-95.59%
OCF growth 3Y-16.25%
OCF growth 5YN/A

BLUELINX HOLDINGS INC / BXC FAQ

What is the fundamental rating for BXC stock?

ChartMill assigns a fundamental rating of 4 / 10 to BXC.


Can you provide the valuation status for BLUELINX HOLDINGS INC?

ChartMill assigns a valuation rating of 2 / 10 to BLUELINX HOLDINGS INC (BXC). This can be considered as Overvalued.


How profitable is BLUELINX HOLDINGS INC (BXC) stock?

BLUELINX HOLDINGS INC (BXC) has a profitability rating of 4 / 10.


Can you provide the expected EPS growth for BXC stock?

The Earnings per Share (EPS) of BLUELINX HOLDINGS INC (BXC) is expected to decline by -77.32% in the next year.